Downloading...
Download

Reversesplit

UVXY: UpdateBears are out to play, seems the winter is over. I'm not looking to dump my position in UVXY just yet, however. I thought I might update the community that Business wire reported that Proshares plans on doing a 1:10 reverse split on May 26th before opening bell that day for their UVXY security. Trade accordingly. I expected a reverse split once it touched the 3's, but with its sharp spike this week I am a little surprised by the announcement and wonder if it will hold tbh. Not advice, not recommendation.
CBOE:UVXY
by deadsquare214
6
VYNE: Entering at a support after reverse stock splitVYNE Therapeutics Inc. has caught my attention recently after they announced a reverse stock split at a ratio of 1-for-4. As a novice trader, I am now interested in observing this stock's behavior as it starts trading on a split-adjusted basis, apparently on February 16th. Consequently, I have opened a position with the belief that the price will see an uptrend. I do not believe stock splits change fundamentals, but there are good reasons to believe that decreased liquidity of stocks may increase the price in the near future. The primary objective of the reverse stock split is to reduce the number of shares outstanding to a number more consistent with other companies with similar market capitalizations as VYNE, as further described in the Company’s last proxy statement (GlobeNewswire). Technical Indicators (1h) Strong support seems to be forming around 2.50 Seems too low volume to justify the current down trend Looking at oversold signals from RSI near support (highlighted in orange) Looking at the MACD for a crossover (highlighted in orange) I have orders set for half my position at 2.65 and half at 2.50 if price drops to that support; I think entering in that range is acceptable. Please feel free to comment on my analysis. Despite having traded for a while, I am fairly new at technical analysis and would love to learn from experienced people in this community.
NASDAQ:VYNELong
by feelsgains
6
NVAX- Dark horse in the vaccine raceNo one can predict the result of NVAX's phase 3 trial. However, I don't count out any potential winners in the vaccine race even though now it seems very likely that NVAX won't be the first one to distribute vaccines at massive scale. That being said, as long as the result of phase 3 trial isn't a complete failure, I think the crowd frenzy will keep pushing NVAX's price up. To be on the safe side, I would market buy 33% of my overall position and limit buy the remaining in the demand zone. Just my opinion. Not the investment advice.
NASDAQ:NVAXLong
by Libratus
UVXY OPTIONS -- NEARING DANGEROUS REVERSE SPLIT TERRITORYBecause UVXY is subject to contango, it periodically has to undergo reverse splits to keep it from going to 0. The last split occurred in May of last year, when UVXY was sub-10 and it is getting close to that area here. In a nutshell, reverse splits wreak havoc with options positions ... . I won't go into the nitty gritty details here, but the Options Clearing Council (OCC) has a specific manner in which it handles options in reverse split situations, the result of which is "non standard contracts" with potential liquidity issues. Because of these concerns, I'm shying away from playing UVXY via options at all until after the split occurs or there is a volatility pop of sufficient depth to save it temporarily from a split. There are, after all, other instruments in which I can go long volatility without the headache of a potential reverse split occurring in the middle of my trade -- SVXY short (which appears to have dodged the split bullet for a while), VXX long (although there are even concerns with reverse splits in that instrument if volatility continues to hang in at low levels), and, of course,VIX options.
CBOE:UVXY
by NaughtyPines
6